Position in ICU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$115,230
+$112,281 QoQ
Shares Held
32,199
+2032.4% QoQ
Ownership
0.731%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 18 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ICU ranks #357 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ICU
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,230 | 31,398 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,949 | 793 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,168 | 13,204 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,922 | 10,391 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $38,974 | 91,491 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $281 | 145 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $220,535 | 29,056 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $955 | 1,837 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,904 | 3,712 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,027 | 4,397 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||